Investing
Shanghai Exchange urges bankers to vet Chinese medical firms IPOs – sources
© Reuters. FILE PHOTO: A men wearing a mask walk at the Shanghai Stock Exchange building at the Pudong financial district in Shanghai, China, as the country is hit by an outbreak of a new coronavirus, February 3, 2020. REUTERS/Aly Song/File Photo
SHANGHAI (Reuters) – The Shanghai Stock Exchange has urged bankers to pay close attention to the marketing practices of Chinese drug and medical equipment makers seeking initial public offerings (IPOs) amid an escalating anti-corruption drive in the sector, sources said.
The bourse asked investment bankers and lawyers to ensure drugmakers’ compliance and legitimacy in sales and marketing activities, according to an internal publication the exchange sent to bankers in late July that was reviewed by Reuters.
Two banking sources familiar with the issue confirmed the information. The Shanghai exchange declined to comment.
Read the full article here
-
Side Hustles4 days ago
Why the Best CEOs Think Like Anthropologists
-
Make Money5 days ago
Earn More in 2025: Top 10 High-Yield Savings Accounts Revealed
-
Passive Income5 days ago
How Pets Can Promote Better Health and Well-Being in the Workplace
-
Side Hustles5 days ago
10 Roles That Are Surprisingly Well-Suited for Outsourcing
-
Side Hustles5 days ago
What to Do If TikTok is Banned — How to Protect Your Brand
-
Make Money6 days ago
Build Your Future: 5 Simple Steps to Financial Stability
-
Side Hustles6 days ago
Meta Is Laying Off 5% of Its Workforce: Read the Memo
-
Investing2 days ago
TikTok faces US ban deadline as users brace for fallout By Reuters